Cubist Systematic Strategies’s DermTech, Inc. Common Stock DMTK Stock Holding History

Cubist Systematic Strategies’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-113,993	Closed	-$632K	–	4842
2022 Q2	$632K	Buy	113,993 +65,315	+134%	+$535K	﹤0.01%	2867
2022 Q1	$715K	Sell	48,678 -27,169	-36%	-$364K	0.01%	2288
2021 Q4	$1.2M	Buy	75,847 +48,859	+181%	+$1.17M	0.01%	1783
2021 Q3	$867K	Buy	26,988 +14,922	+124%	+$524K	0.01%	1636
2021 Q2	$502K	Buy	12,066 +6,986	+138%	+$287K	0.01%	2005
2021 Q1	$258K	Buy	+5,080	New	+$266K	﹤0.01%	2340

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIA

Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cubist Systematic Strategies's DMTK Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 113,993 shares — an estimated $632K sold.

Cubist Systematic Strategies first reported a position in DMTK in Q1 2021 and held it in 6 quarters. The position peaked at $1.2M in Q4 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

Cubist Systematic Strategies reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 113,993 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $632K.
Cubist Systematic Strategies first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Cubist Systematic Strategies's DermTech, Inc. Common Stock position peaked at $1.2M in Q4 2021.
127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.